Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-012124

SVP & General Counsel sold 2,173 shares at $22.37 ($48,610)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2021-02-16 Sale −2,173 $22.37 $48,610 76,727 D: show line 1 in the form
Open-market sales · 2,173 sh · avg $22.37 · $48,610
Loading xslF345X03/doc4.xml…